Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
KPTI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KPTI - Karyopharm Therapeutics Inc.
1.12 M
LAST VALUE
-87.65%
2 YEAR CAGR
-67.63%
5 YEAR CAGR
-40.00%
10 YEAR CAGR